SiteBridge Research, together with iParticipate, is kicking off its annual Bridging the Gap in Clinical Trials Arts contest. This effort officially launches SiteBridge's community engagement program and aims to connect the arts, sciences, and community in support of clinical trial participation.
The contest began on June 14 with voting commencing on August 7. Winners will be notified on November 20. It will feature talent across four categories: visual art, music, photography, and dance.
SiteBridge's creative collaboration with iParticipate, incorporated in the "Bridging the Gap" initiative compels industry to examine how it addresses disparities and how it portrays clinical trials—especially to communities of color and other underrepresented populations—and will explore the potential for impact.
Read more about the initiative and contest here.
Bridging the Gap Community Engagement Program. (2023, June 14). SiteBridge Research.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
FDA-Approved Gene Therapy Beqvez Shows Sustained Efficacy, Safety in Long-Term Hemophilia B Trial
April 17th 2025Beqvez (fidanacogene elaparvovec), an FDA-approved one-time gene therapy for hemophilia B, demonstrated sustained factor IX expression, low bleeding rates, and a favorable safety profile over long-term follow-up.